Disruption of Apc within hepatocytes activates Wnt signaling, perturb differentiation and ultimately lead to neoplasia. Apc negatively regulates Wnt signaling but is also involved in organizing the cytoskeleton and may play a role in chromosome segregation. In vitro studies have implicated Apc in the control of genomic stability. However, the relevance of this data has been questioned in vivo as Apc is lost earlier than the onset of genomic instability. Here, we analyse the relationship between immediate loss of Apc and the acquisition of genomic instability in hepatocytes. We used Cre-lox technology to inactivate Apc and in combination with p53 in vivo, to define the consequences of gene loss upon cell-cycle regulation, proliferation, death and aneuploidy. We show that whilst Apc loss leads to increased proliferation, it also leads to increased apoptosis, the accumulation of p53, p21 and markers of DSBs and DNA repair. Flow cytometry revealed an increased 4N DNA content, consistent with a G2 arrest. Levels of anaphase bridges were also elevated, implicating failed chromosome segregation. This was accompanied by an increase in centrosome number which demonstrates a role for Apc in maintaining euploidy.
Introduction
Inactivation of the APC (adenomatous polyposis coli) gene marks one of the earliest events in colorectal cancer (CRC) [1] . Apc is part of the destruction complex that controls the level of β-catenin in the Wnt signaling pathway [2] . However, Apc is also involved in the organization of the cytoskeleton, the regulation of cell migration and localizes to kinetochores, centrosomes and microtubules [3] [4] [5] [6] [7] . Indeed, APC may regulate kinetochoremicrotubule attachment at centrosomes and this could influence centrosome duplication or nucleation during mitosis. Mouse embryonic stem cells (ES) homozygous for Apc Min (Apc Δ850 ) display extensive chromosome and spindle aberrations, providing genetic evidence for a role of APC in chromosome segregation [3] . All this is suggestive that Apc may be important in maintaining genomic stability (GI), and therefore that Apc loss may also drive CRC through the acquisition of GI. To this end it has been suggested that GI is an early hallmark of CRC [3, 4, 8] . However, there remains some controversy over the stage at which GI is acquired, as adenomas driven by Apc gene deletion are thought to be genetically stable.
Previously we have shown that Apc loss in MEFs and the murine intestinal epithelium leads to an increase in DNA damage, nuclear atypia, upregulation of p53 and p21 and an increase in cells with DNA greater than 4N, suggesting tetraploidy [5] . However, p53 only weakly altered the immediate phenotype of Apc loss in the mouse intestine [9] . In the kidney, it was previously found that Apc deficiency results in a predisposition to renal carcinoma and that p53 deficiency accelerated the onset of tumour formation [10] .
Within adenomas formed after β-catenin activation or Apc Δ716 truncation, an increase in anaphase bridges has been reported, therefore suggesting a level of chromosome instability (CIN) [11] . Consistent with this, a high index of anaphase bridges was found in gastric cancers with Wnt signaling activation and it was suggested that p53 dysfunction and Wnt signaling may cooperate to increase CIN in the progression of the intestinal-type gastric cancer [11] .
Wnt signaling is a major pathway involved in the control of liver metabolism and zonation [12] . Activation of Wnt signaling is also a key oncogenic event in hepatocellular carcinoma (HCC) [13] . Several Wnt pathway components have been implicated in HCC such as Axin2 and APC [14] [15] [16] . For example, conditional deletion of Axin1 has been shown to lead to HCC in mice [15] and hypermethylation of the sense strand of the APC gene has been shown to be specific for hepatocellular carcinoma [16] . P53 has also been shown to be mutated in HCC [17] and has been shown to have a role in CIN in human HCC [14, 18] , but is mutated only late in disease progression.
Given this strong association of deregulated Wnt signaling and HCC, we have used Cre-lox technology to delete Apc within mouse hepatocytes. Following Cre induction, mice developed hepatomegaly, with an increase in hepatocyte proliferation [19] . The phenotype was shown to be due to a deregulation of the Wnt pathway as co-deletion of β-catenin following Apc loss rescued these phenotypes [19] . Using this clean genetic system (lacking other events that occur during carcinogenesis) we tested whether Apc loss directly leads to Méniel et al. Page 2 Oncogene. Author manuscript; available in PMC 2016 January 30.
Europe PMC Funders Author Manuscripts GI. Given the cooperation of Apc and p53 loss in driving liver carcinogenesis, we also assessed whether additional deletion of p53 had a direct role in GI driven by Apc deletion.
Results

Loss of Apc in the liver leads to DNA damage, DNA repair and proliferation
Induction of AhCre + mice with β-naphthoflavone delivers high levels of recombination in the liver [19] . To yield near 100% recombination in hepatocytes we induced male mice with 3 injections of β-naphthoflavone, however the AhCre + Apc fl/fl mice became ill due to the previously described intestinal phenotype [24] at D4 and were therefore killed. In order to allow the mouse to progress to a more advanced phenotype in hepatocytes we induced female mice (as they usually have lower recombination rates in the intestine) with a single injection of β-naphthoflavone and sacrificed the mice at D6. This protocol leads to a lower level of recombination in the intestine, but retains high levels of recombination in the liver, as evidenced by elevated nuclear β-catenin as a surrogate marker for Apc recombination (>80%) in AhCre + Apc fl/fl at D4 and D6 (FigSup1A-B).
As previously shown [19] , we confirmed that Apc loss leads to hepatomegaly (FigSup1C), and determined that this was not a result of increased cell size (FigSup1D). We next determined if hepatomegaly was reflected by an increase in BrdU incorporation (which labels cells in S phase) or Ki67 levels (which labels cells in active phases of the cell cycle (G(1), S, G(2), and mitosis To further test our hypothesis that loss of Apc causes G2 arrest, we performed dual immunostaining with Phospho-Histone H3 (P-histone H3) and BrdU 24hrs after injection of BrdU. P-histone H3 expression serves as a good marker for detecting progression into mitosis from late G2, as its expression is detected from late G2 to early telophase [25] . We compared this pattern of staining to BrdU labelling 24hrs after BrdU exposure. We hypothesized that, in the absence of a G2 arrest, cells labelled with BrdU at S phase will proceed to mitosis and label with both Brdu and P-histone H3. 
Loss of Apc leads to an increase in anaphase bridges
Previously, the presence of anaphases bridges has been linked to CIN. Aneuploidy, an altered chromosome number, which is not a direct multiplication of the normal haploid number, is a common feature of human cancer [26] . Multiple defects occurring during mitosis such as mitotic checkpoint errors, can result in aneuploidy potentially through centrosome amplification [26] [27] [28] . 
Discussion
Activation of the Wnt pathway following loss of APC is one of the most important drivers of CRC and is also a key oncogenic event in HCC. For example, a recent extensive study in 125 HCC found that the Wnt/β-catenin pathway was the most frequently altered pathway, with 32.8% of HCCs being mutated in CTNNB1, 15.2% in AXIN1, and 1.6% in APC genes [29] . However, there are other mechanisms by which Apc loss may impact upon tumorigenesis, as it is also implicated in the binding and stabilization of microtubules and chromosome segregation [6, 7] . It is generally accepted that Apc loss occurs in the early stages of CRC, though its role in CIN is still debated. To study the role of the early loss of Apc in GI in the liver, we conditionally deleted Apc and found that Apc loss immediately drives increased proliferation which is accentuated by p53 deficiency. This is in contrast to the situation in the small intestine, where p53 deficiency only weakly affects the phenotype of Apc loss [9] .
To perform the analyses in the liver, we used two induction protocols, one harvested at D4 and one at D6. For the D4 time point we used our standard protocol (inducing male mice with 3 injections in 1 day), which results in near 100% recombination in both the intestine and liver. However, as our standard protocol compromises animal health beyond D4 due to the intestinal phenotype, the D6 time point was generated using a reduced induction protocol (a single injection of β-naphthoflavone) to minimize any adverse effects from recombination in the intestine. Surprisingly, the level of recombination in the hepatocytes, as assessed by nuclear β-catenin levels, was found to be similar at D4 and D6. All analyses were performed at both time points but some differences were observed. In the CTRLs, we observed differences in the levels of cleaved Caspase3 positive cells with a significant increase at D4 compared to D6. This may be due to the toxicity of the inducing agent β-naphthoflavone which has been shown to generate DNA damage and cell cycle check points [30] . mutant an increase at D6 of cells with nuclei with more than 2 centrosomes compared to D4. This could be due to the additional loss of P53 which in the D6 time point is permissive for the Apc mutant cells to develop genomic instability. Some trends and differences were also observed with the FACS analysis. The trend for an increase in the 4N population between D4 and D6 did not reach significance (P=0.2593), however a significant difference was observed in the proportion of nuclei with greater than 4N DNA content (18.4% at D4 vs 7.6% at D6). Again, this may reflect an increase in the elapsed time from induction.
The increase in proliferation following Apc loss is associated with hepatomegaly. This has been previously reported [19] and correlates with β-catenin activation and ultimately HCC [13] . However, we do not see a further increase in liver size in AhCre + Apc fl/fl p53 −/− , despite observing elevated proliferation. Hence, in our model there is dissociation between hepatomegaly and proliferation. This dissociation may reflect the increased levels of apoptosis we observe in AhCre + Apc fl/fl p53 −/− , with the increased loss of hepatocytes compensating for the increased proliferation.
One likely reason for the increased rate of apoptosis is an increase in DNA damage, as evidenced by the accumulation of DSBs (γH2AX) and presence of DNA repair (Rad51). DSBs are a major threat to genome integrity and DSB repair pathways have evolved to preserve cell survival and DNA integrity [31] . The increase in Rad51 and γH2AX positive cells indicates elevated DNA damage following loss of Apc, the repair of which is normally mediated by p53. The consequence of this is elevated cell death in the double mutant, which is clearly occurring in a p53-dependent manner.
The key question is how does Apc loss lead to elevated DNA Damage? Recently it has been shown that mitotic spindle defects can generate DSBs by centromere shearing [32] . As Apc loss leads to mitotic spindle defects [33] , it is therefore possible that the DSBs observed are a direct consequence of spindle defects.
Previous studies have suggested a role for Apc within the cell cycle. Our data shows an accumulation of cells with 4N DNA content which is consistent with a G2 arrest. APC has been shown to localize to kinetochores, centrosomes and microtubules [7] . Indeed APC may regulate kinetochore microtubule attachment at centrosomes and this could influence mitosis. We show that the effects observed on 2N and 4N DNA content after Apc loss are dependent upon the presence of functional p53. p53 has been shown previously to play a role in both the G1/S and G2/M arrests which are mechanisms employed by the cells to prevent GI [34, 35] . To further explore the role of p53 we performed double labelling with antibodies to BrdU and P-histone H3 to analyse progression from G2 to M phase. At both D4 and D6 we observed a decrease in the percentage of doubly labelled cells in the APC mutants compared to Wt, thereby suggesting G2/M arrest. However, additional loss of p53 led to a partial rescue of this phenotype to almost Wt levels. These data indicate that additional loss of p53 enables some of the cells to progress through the G2-M phase. We therefore suggest that Apc loss leads to a G2/M arrest and that p53 plays a role in maintaining this arrest.
Our FACS data indicate that in a p53 deficient background, Apc loss leads to an increase in DNA content greater than 4N and consistent with aneuploidy. This increase is concomitant with an increase in anaphase bridges. We observe that anaphases bridges occur even in the early stages of Apc loss. Anaphase bridges are susceptible to breakages [36, 37] which results in gross chromosomal rearrangements, translocations, or deletion. Similarly, aberrant mitotic division has been shown to result in aneuploidy [38] . Anaphase bridges in ES cells carrying Apc Min were correlated with an increase or decrease in chromosome numbers suggesting aneuploidy [4] . Our data shows a change in the chromosome number correlated with an increase in centrosome number after loss of Apc. Increase in centrosome number has been linked to failure to complete cytokinesis and skipping mitosis. It is well established that centrosome amplification contributes to aneuploidy which is linked to chromosome segregation errors during mitosis [28] . All of this data is in accordance with an early role for Apc in maintaining euploidy. However, our data also show that p53 deficiency does not enhance the effects of Apc loss on anaphase bridge formation and centrosome amplification. This is in contrast with the data observed for yH2AX, Rad51, cell proliferation, cell death and DNA content where the addition of p53 deficiency significantly increases the Apc loss phenotype which supports the role of p53 in protecting the genome against mitotic defects and aneuploidy. It is therefore possible that the marginal effect of p53 deficiency after Apc loss on anaphase bridge formation, chromosome number and centrosome amplification is due to the increase cell death observed in the double mutant. For example, the cells in the double mutant could have undergone mitotic catastrophe leading to cell death with the net result of a marginal increase in anaphase bridge formation, chromosome number and centrosome amplification. This mechanism, which has been previously described [39] , would therefore limit the extent of genomic instability.
As discussed above, Apc plays a critical role in regulating the levels of activated β-catenin.
A role for β-catenin in CIN has also been described [40] , and one could argue that the aneuploidy we observe is directly due to activation of β-catenin. Conversely, there are data which show that in Apc Min mice aneuploidy is observed in intestinal cells with a normal level of activated β-catenin [41] . Clearly, further studies are needed to define the extent to which activated β-catenin may drive aneuploidy in the absence of Apc.
Previously it was shown that Apc loss in the small intestine rapidly leads to tetraploidy but that p53 has very little role in this process although the loss of p53 did alter the transcriptome following Apc loss [5] . In the longer term, p53 deficiency again only marginally altered intestinal adenoma predisposition in the Apc Min mouse [42] . By contrast, Apc and p53 mutations have been shown to synergise in driving renal tumourigenesis [10] , although limited short term data has been reported. The data we show here suggest that p53 status is more important in controlling Wnt driven genomic instability in hepatocytes as compared to enterocytes. Given the lack of immediate genomic instability data from the kidney and also the lack of long term tumourigenesis data from the liver, this makes tissue specific comparisons difficult, and indeed highlights the need for additional studies.
In summary, our data shows that Apc deficiency leads to perturbation of the cell cycle, elevated DNA damage, the accumulation of p53 and apoptosis. We show that anaphase bridges occur even in the early stages of Apc loss, suggesting the development of aneuploidy. Our data also show an increase in chromosome and centrosome numbers after loss of Apc confirming a role for Apc in maintaining euploidy. In the additional absence of p53, many of these effects are accentuated suggesting that p53 has a role in protecting the genome against mitotic defects generated by the loss of Apc however this does not result in a clear increase in anaphase bridges and centrosome numbers. Our data suggest that combined Apc and p53 deficiency does enhance the signal of DNA damage but this does not translate into immediate enhanced genomic instability as the DNA damage signal may be at least partially compensated for by elevated cell death through mitotic catastrophe.
Material and Methods
Experimental animals
All experiments were performed under the U.K. Home Office guidelines. Outbred mice segregating for the C57BLJ and S129 genomes (6-12 weeks) were used. Mice were obtained and genotyped as follows: Apc 580S (Apc fl ) [20] , AhCre [21] , p53null (p53 − ) [22] . i.p injection of 80mg/kg (Day0) and sacrificed and dissected 6 days later at Day6 (D6). For proliferation analysis, mice were injected either 2hrs or 24hrs before culling with 0.25 ml of BrdU (Amersham).
Histology and Immunohistochemistry
Liver tissue was fixed in ice-cold 10% formalin and paraffin embedded tissue sections (5μm) were used for immunohistochemistry (IHC). Ki67, Caspase3, BrdU, P21, p53, γH2AX immunohistochemistry (IHC) were performed as previously described [9, 19] 
Immunofluorescence for double labelling of BrdU and phospho-histone H3
Liver tissue was fixed in ice-cold 10% formalin and paraffin embedded tissue sections (5μm) were used for IHC. Antigen retrieval was performed in 1×citrate buffer in microwave pressure cooker. We used 1/200 dilution of BrdU plus Phospho-histone H3 antibodies (phospho-histone H3:Cell signalling #9701; BrdU BD). Phospho-histone H3 (P-histone H3) was detected using a biotinylated goat Anti-Rabbit antibody (Dako) and the AB reagents from Vectastain (Vector labs). The fluorescent signal was provided using the Fluorescein Tyramide Signal Amplification (TSA) Systems (Perkin elmer). BrdU antibody was detected using a goat anti mouse 1/200 Alexa 568 antibody (Molecular Probes life technologies). Cells were counterstained with Dapi (500ng/ml) and slides were mounted with mowiol. Pictures were taken using a Leica DMI6000 time lapse microscope.
Nuclear area
The area (μm 2 ) of nuclei was assessed using Hematoxylin-Eosin (H and E) stained section after image capture using Analysis software (Soft Imaging Systems). At least 200 nuclei per mouse from N=3 or more mice of each genotype were measured and the moving average test was used to analyze the data.
DNA content using Flow cytometry
Fresh livers were minced with a scalpel. Cells were suspended in 1ml of 0.1M citric acid, 0.5% vol/vol Tween20 solution, shaken for 20min at 20°C, passed through a 50-100-μm sieve and fixed with 70% ethanol. DRAQ5 (Biostatus-limited) was added to a concentration of 20μM before the detection of DNA content using FACS-caliber (Becton-Dickinson).
Percentage of cells with 2N DNA content, 4N, DNA content between 2N and 4N (S phase) or greater than 4N (4N<) was determined for each mice, from N=3 or more mice of each genotype. 10 000 events were counted in total for each mouse. The data generated are given as a percentage for each DNA content 2N, S, 4N, and greater than 4N. The percentage for 
Liver culture and chromosome spread
Mouse Primary hepatocytes were isolated by liver perfusion medium using a 2-step retrograde procedure. Hepatocytes were purified using percoll-gradient and plated on a fibronectin coated plate as previously described [23] . Chromosome spreads were generated after 2 days of culture. 2hrs before harvest, hepatocytes in culture were supplemented with ethidium bromide (1.5μg/ml). Colcemid (Karyomax) was added (0.1μg/ml) 40min later and left for 80min at 37°C. Cells were then collected and resuspended in 75mM KCL for 5min and fixed with ice-cold Methanol-acetic-acid solution (3/1Volume). Cells were analysed for chromosomes numbers (at least 20 chromosome spreads were counted).
Centrosome staining
Liver cryosections (5μm) were fixed with 4% paraformaldehyde and blocked for 1 hour with mouse IgG blocking reagent (vector labs). After blocking with Donkey serum (5% in PBS-0.3%Tween), sections were incubated with 1/500 anti-pericentrin antibody (Abcam) overnight. Secondary 1/500 Anti-rabbit Cy3 (Jackson immunoresearch, stratech) and 1/500 Alexafluor 488 -phalloidin (invitrogen) was then applied on the sections for 1-2hours. Sections were mounted with vectashield plus DAPI medium. Sections were viewed and analysed using a Leica TCS SP2 spectral confocal microscope and Leica confocal software (Leica, Heidelberg, Germany). Centrosomes numbers were counted in at least 150 nuclei of hepatocytes from each mouse for each genotype (N=3-5) at D4 and D6.
Statistics
Histograms comparison was performed using Mann-Whitney U test (MiniTab). Cumulative frequency and % nuclear size comparison was performed using the Kolmogorov-Smirnov test. For the anaphase bridges data, in the control cohort D4, there was no variation with all values being zero. Mann Whitney test completion was impossible because all values in one column were identical. We therefore used a bootstrapping method in order to perform a more powerful statistical test on the data and determine the 95% confidence intervals. The mean of the AhCre + Apc fl/fl group D4 was bootstrapped, therefore, groups were assessed as significantly different if AhCre + Apc fl/fl 95% confidence intervals did not overlap this zero value. Oncogene. Author manuscript; available in PMC 2016 January 30.
